Abstract
Positron Emission Tomography (PET) is a method for determining biochemical and physiological processes in vivo in a quantitative way. This includes the measurement of the pharmacokinetics of labeled drugs and the measurement of the effects of drugs and/or therapy on metabolism. Also deviations of normal metabolism can be measured and insight in biological processes responsible for diseases can be obtained. To accomplish these measurements a multi-disciplinary team is necessary for the expertise in the fields of radionuclide production, radiochemistry, pharmacy, medicine, nuclear imaging and data analysis.
| Original language | English |
|---|---|
| Pages (from-to) | 150-153 |
| Number of pages | 4 |
| Journal | Acta neurologica belgica |
| Volume | 97 |
| Issue number | 3 |
| Publication status | Published - Sept-1997 |
| Event | International Symposium on Nuclear Medicine and Clinical Neurology - , Belgium Duration: 7-Mar-1997 → 8-Mar-1997 |
Keywords
- PET
- radionuclide production
- PET-scanner
- NeuroPet
- data analysis